1 / 31

Global Artificial Intelligence In Genomics Market Forecast 2026

According to the MarkNtel Advisors research report Global Artificial Intelligence in Genomics Market Analysis 2021 the market is expected to grow at a CAGR of around 53% during (2021-26). <br><br>Reports URL - https://www.marknteladvisors.com/research-library/global-artificial-intelligence-in-genomics-market.html

marknteladvisors
Download Presentation

Global Artificial Intelligence In Genomics Market Forecast 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Artificial Intelligence in Genomics Market Analysis, 2021 marknteladvisors.com

  2. Document Outline Table of Content Study Background, Market Segmentation, Scope of Work 02 Research Process & Methodology Research Approach, Research Methodology 17 Sample Illustration Global Artificial Intelligence in Genomics Market Analysis, 2021 28 Commercials 70 Company Profile About the company 72 Contact Details 74 2 2 © 2021. All Rights Reserved | MarkNtel Advisors

  3. Market Segmentation Global Artificial Intelligence in Genomics Market By Offering By Application By Technology By Functionality By Region Genome Sequencing • • Software Diagnostics • Machine Learning • • North America • The US • Canada • Mexico • South America • Brazil • Others • Europe • Germany • The UK • France • Italy • Spain • Others • Middle East & Africa • GCC • South Africa • Others • Asia Pacific China India Japan South Korea Others • • • • • Gene Editing • • Services Precision Medicine • Deep Learning • Predictive Genetic Testing & • Drug Discovery & • Others • Preventive Medicine Development Agriculture & Animal • Research By Company By End User Pharmaceutical Companies • Deep Genomics Inc. FDNA Inc. Congenica Ltd. • • • Research Centers, Academic • IBM Benevolent AI Lantern Pharma, Inc. • • • Institutes Microsoft Freenome Holdings, MolecularMatch, Inc. • • • Healthcare Providers • Fabric Genomics, Inc. Empiric Logic • • Government Organizations • Inc. Sophia Genetics Limited • Verge Analytics, Inc. Ardigen Lifebit • • • 3 © 2021. All Rights Reserved | MarkNtel Advisors

  4. Study Background – Project Outline (1/12) Historical Year: 2016 | Base Year: 2020 | Forecast Year: 2026 Table of Content 1. Introduction 1.1. Product Definition 1.2. Research Process 1.3. Assumptions 1.4. Market Segmentation Preface Executive Summary Impact of COVID-19 on Global Artificial Intelligence in Genomics Market Global Artificial Intelligence in Genomics Market Trends & Insights Global Artificial Intelligence in Genomics Market Dynamics 6.1. Drivers 6.2. Challenges 6.3. Impact Analysis Global Artificial Intelligence in Genomics Market Hotspots & Opportunities Global Artificial Intelligence in Genomics Market Value Chain Analysis Global Artificial Intelligence in Genomics Market Regulations & Policy 10. Global Artificial Intelligence in Genomics Market Start-up Ecosystem, 2016-2021 10.1. Entrepreneurial Activity 10.2. Year On Year Funding Received 10.3. Funding Received by Top Companies 2. 3. 4. 5. 6. 7. 8. 9. 4 © 2021. All Rights Reserved | MarkNtel Advisors

  5. Study Background – Project Outline (2/12) Historical Year: 2016 | Base Year: 2020 | Forecast Year: 2026 Table of Content 10.4. Key Investors Active in the Market 10.5. Series Wise Funding Received 10.5.1. Seed Funding 10.5.2. Angel Investing 10.5.3. Venture Capitalists (VC) Funding 10.5.4. Others 11. Global Artificial Intelligence in Genomics Market Outlook, 2016-2026F 11.1. Market Size & Analysis 11.1.1. By Revenues 11.2. Market Share & Analysis 11.2.1. By Offering 11.2.1.1. Softwares 11.2.1.2. Services 11.2.2. By Technology 11.2.2.1. Machine Learning 11.2.2.1.1. Deep Learning 11.2.2.2. Other Technologies 11.2.3. By Functionality 11.2.3.1. Gene Editing 11.2.3.2. Genome Sequencing 5 © 2021. All Rights Reserved | MarkNtel Advisors

  6. Study Background – Project Outline (3/12) Historical Year: 2016 | Base Year: 2020 | Forecast Year: 2026 Table of Content 11.2.3.3. Predictive Genetic Testing & Preventive Medicine 11.2.4. By Application 11.2.4.1. Diagnostics 11.2.4.2. Precision Medicine 11.2.4.3. Drug Discovery & Development 11.2.4.4. Agriculture & Animal Research 11.2.5. By End User 11.2.5.1. Pharmaceutical Companies 11.2.5.2. Research Centers, Academic Institutes 11.2.5.3. Healthcare Providers 11.2.5.4. Government Organizations 11.2.6. By Region 11.2.6.1. North America 11.2.6.2. South America 11.2.6.3. Europe 11.2.6.4. Middle East & Africa 11.2.6.5. Asia Pacific 11.2.7. By Competitors 11.2.7.1. Competition Characteristics 11.2.7.2. Market Share & Analysis 6 © 2021. All Rights Reserved | MarkNtel Advisors

  7. Study Background – Project Outline (4/12) Historical Year: 2016 | Base Year: 2020 | Forecast Year: 2026 Table of Content 11.2.7.3. Competitive Matrix 12. North America Artificial Intelligence in Genomics Market Outlook, 2016-2026F 12.1. Market Size & Analysis 12.1.1. By Revenue 12.2. Market Share & Analysis 12.2.1. By Offering 12.2.2. By Technology 12.2.3. By Functionality 12.2.4. By Application 12.2.5. By End User 12.2.6. By Country 12.2.6.1. The US 12.2.6.2. Canada 12.2.6.3. Mexico 12.3. The US Artificial Intelligence in Genomics Market Outlook, 2016-2026F 12.3.1. Market Size & Analysis 12.3.1.1. By Revenue 12.3.2. Market Share & Analysis 12.3.2.1. By Offering 12.3.2.2. By Technology 7 © 2021. All Rights Reserved | MarkNtel Advisors

  8. Study Background – Project Outline (5/12) Historical Year: 2016 | Base Year: 2020 | Forecast Year: 2026 Table of Content 12.4. Canada Artificial Intelligence in Genomics Market Outlook, 2016-2026F 12.4.1. Market Size & Analysis 12.4.1.1. By Revenue 12.4.2. Market Share & Analysis 12.4.2.1. By Offering 12.4.2.2. By Technology 12.5. Mexico Artificial Intelligence in Genomics Market Outlook, 2016-2026F 12.5.1. Market Size & Analysis 12.5.1.1. By Revenue 12.5.2. Market Share & Analysis 12.5.2.1. By Offering 12.5.2.2. By Technology 13. South America Artificial Intelligence in Genomics Market Outlook, 2016-2026F 13.1. Market Size & Analysis 13.1.1. By Revenue 13.2. Market Share & Analysis 13.2.1. By Offering 13.2.2. By Technology 13.2.3. By Functionality 13.2.4. By Application 8 © 2021. All Rights Reserved | MarkNtel Advisors

  9. Study Background – Project Outline (6/12) Historical Year: 2016 | Base Year: 2020 | Forecast Year: 2026 Table of Content 13.2.5. By End User 13.2.6. By Country 13.2.6.1. Brazil 13.2.6.2. Others 13.3. Brazil Artificial Intelligence in Genomics Market Outlook, 2016-2026F 13.3.1. Market Size & Analysis 13.3.1.1. By Revenue 13.3.2. Market Share & Analysis 13.3.2.1. By Offering 13.3.2.2. By Technology 14. Europe Artificial Intelligence in Genomics Market Outlook, 2016-2026F 14.1. Market Size & Analysis 14.1.1. By Revenue 14.2. Market Share & Analysis 14.2.1. By Offering 14.2.2. By Technology 14.2.3. By Functionality 14.2.4. By Application 14.2.5. By End User 14.2.6. By Country 9 © 2021. All Rights Reserved | MarkNtel Advisors

  10. Study Background – Project Outline (7/12) Historical Year: 2016 | Base Year: 2020 | Forecast Year: 2026 Table of Content 14.2.6.1. Germany 14.2.6.2. The UK 14.2.6.3. France 14.2.6.4. Spain 14.2.6.5. Italy 14.2.6.6. Others 14.3. Germany Artificial Intelligence in Genomics Market Outlook, 2016-2026F 14.3.1. Market Size & Analysis 14.3.1.1. By Revenue 14.3.2. Market Share & Analysis 14.3.2.1. By Offering 14.3.2.2. By Technology 14.4. The UK Artificial Intelligence in Genomics Market Outlook, 2016-2026F 14.4.1. Market Size & Analysis 14.4.1.1. By Revenue 14.4.2. Market Share & Analysis 14.4.2.1. By Offering 14.4.2.2. By Technology 14.5. France Artificial Intelligence in Genomics Market Outlook, 2016-2026F 14.5.1. Market Size & Analysis 10 © 2021. All Rights Reserved | MarkNtel Advisors

  11. Study Background – Project Outline (8/12) Historical Year: 2016 | Base Year: 2020 | Forecast Year: 2026 Table of Content 14.5.1.1. By Revenue 14.5.2. Market Share & Analysis 14.5.2.1. By Offering 14.5.2.2. By Technology 14.6. Spain Artificial Intelligence in Genomics Market Outlook, 2016-2026F 14.6.1. Market Size & Analysis 14.6.1.1. By Revenue 14.6.2. Market Share & Analysis 14.6.2.1. By Offering 14.6.2.2. By Technology 14.7. Italy Artificial Intelligence in Genomics Market Outlook, 2016-2026F 14.7.1. Market Size & Analysis 14.7.1.1. By Revenue 14.7.2. Market Share & Analysis 14.7.2.1. By Offering 14.7.2.2. By Technology 15. Middle East & Africa Artificial Intelligence in Genomics Market Outlook, 2016-2026F 15.1. Market Size & Analysis 15.1.1. By Revenue 15.2. Market Share & Analysis 11 © 2021. All Rights Reserved | MarkNtel Advisors

  12. Study Background – Project Outline (9/12) Historical Year: 2016 | Base Year: 2020 | Forecast Year: 2026 Table of Content 15.2.1. By Offering 15.2.2. By Technology 15.2.3. By Functionality 15.2.4. By Application 15.2.5. By End User 15.2.6. By Country 15.2.6.1. GCC 15.2.6.2. South Africa 15.2.6.3. Others 15.3. GCC Artificial Intelligence in Genomics Market Outlook, 2016-2026F 15.3.1. Market Size & Analysis 15.3.1.1. By Revenue 15.3.2. Market Share & Analysis 15.3.2.1. By Offering 15.3.2.2. By Technology 15.4. South Africa Artificial Intelligence in Genomics Market Outlook, 2016-2026F 15.4.1. Market Size & Analysis 15.4.1.1. By Revenue 15.4.2. Market Share & Analysis 15.4.2.1. By Offering 12 © 2021. All Rights Reserved | MarkNtel Advisors

  13. Study Background – Project Outline (10/12) Historical Year: 2016 | Base Year: 2020 | Forecast Year: 2026 Table of Content 15.4.2.2. By Technology 16. Asia Pacific Artificial Intelligence in Genomics Market Outlook, 2016-2026F 16.1. Market Size & Analysis 16.1.1. By Revenue 16.2. Market Share & Analysis 16.2.1. By Offering 16.2.2. By Technology 16.2.3. By Functionality 16.2.4. By Application 16.2.5. By End User 16.2.6. By Country 16.2.6.1. China 16.2.6.2. India 16.2.6.3. Japan 16.2.6.4. South Korea 16.2.6.5. Others 16.3. China Artificial Intelligence in Genomics Market Outlook, 2016-2026F 16.3.1. Market Size & Analysis 16.3.1.1. By Revenue 16.3.2. Market Share & Analysis 13 © 2021. All Rights Reserved | MarkNtel Advisors

  14. Study Background – Project Outline (11/12) Historical Year: 2016 | Base Year: 2020 | Forecast Year: 2026 Table of Content 16.3.2.1. By Offering 16.3.2.2. By Technology 16.4. India Artificial Intelligence in Genomics Market Outlook, 2016-2026F 16.4.1. Market Size & Analysis 16.4.1.1. By Revenue 16.4.2. Market Share & Analysis 16.4.2.1. By Offering 16.4.2.2. By Technology 16.5. Japan Artificial Intelligence in Genomics Market Outlook, 2016-2026F 16.5.1. Market Size & Analysis 16.5.1.1. By Revenue 16.5.2. Market Share & Analysis 16.5.2.1. By Offering 16.5.2.2. By Technology 16.6. South Korea Artificial Intelligence in Genomics Market Outlook, 2016-2026F 16.6.1. Market Size & Analysis 16.6.1.1. By Revenue 16.6.2. Market Share & Analysis 16.6.2.1. By Offering 16.6.2.2. By Technology 14 © 2021. All Rights Reserved | MarkNtel Advisors

  15. Study Background – Project Outline (9/12) Historical Year: 2016 | Base Year: 2020 | Forecast Year: 2026 Table of Content 17. Key Strategic Imperatives for Success and Growth 18. Competition Outlook 18.1. Competition Matrix 18.1.1. Product Portfolio 18.1.2. Target Markets 18.1.3. Target End Users 18.1.4. Research & Development 18.1.5. Strategic Alliances 18.1.6. Strategic Initiatives 18.2. Company Profiles 18.2.1. Deep Genomics Inc. 18.2.2. IBM 18.2.3. Microsoft Corporation 18.2.4. Fabric Genomics, Inc. 18.2.5. Verge Analytics, Inc. 18.2.6. FDNA Inc. 18.2.7. Benevolent AI 18.2.8. Freenome Holdings, Inc. 18.2.9. SOPHIA GENETICS 18.2.10. Ardigen 15 © 2021. All Rights Reserved | MarkNtel Advisors

  16. Study Background – Project Outline (10/12) Historical Year: 2016 | Base Year: 2020 | Forecast Year: 2026 Table of Content 18.2.11. Congenica Ltd. 18.2.12. Lantern Pharma, Inc. 18.2.13. MolecularMatch, Inc. 18.2.14. Empiric Logic Limited 18.2.15. Lifebit 19. Disclaimer 16 © 2021. All Rights Reserved | MarkNtel Advisors

  17. Document Outline Table of Content Study Background, Market Segmentation, Scope of Work 02 Research Process & Methodology Research Approach, Research Methodology 17 Sample Illustration Global Artificial Intelligence in Genomics Market Analysis, 2021 28 Commercials 70 Company Profile About the company 72 Contact Details 74 17 17 © 2021. All Rights Reserved | MarkNtel Advisors

  18. Global Artificial Intelligence in Genomics Market Start-up Ecosystem, 2016-2021

  19. Global Artificial Intelligence in Genomics Market Investments Ecosystem (1/5) Figure XX: Global Artificial Intelligence in Genomics Market Number of Start-ups Launched/Registered, 2016-2021 2016 2017 2018 2019 2020 2021 Figure XX: Global Artificial Intelligence in Genomics Market Investment Trend By Investors, 2016-2021 2016 2017 2018 2019 2020 2021 Tim Ventures XX XX. XX, XX.. Source: MarkNtel Advisors 19 © 2021. All Rights Reserved | MarkNtel Advisors

  20. Global Artificial Intelligence in Genomics Market Outlook, 2016- 2026F

  21. Global Artificial Intelligence in Genomics Market, By Revenues (1/6) Figure XX: Global Artificial Intelligence in Genomics Market Revenues (USD Million), 2016-26F CAGR: X% CAGR: X% COVID-19 Impact 2016 2017 2018 2019 2020 2021F 2022F 2023F 2024F 2025F 2026F Source: MarkNtel Advisors Overview • The global Artificial Intelligence in genomics market was valued at X billion in 2020 and is projected to reach X billion by 2026, registering a compound annual growth rate (CAGR) of X% between 2021 and 2026 in terms of value. The growth in the AI in Genomics market can be attributed to the significant adoption of AI in the large number of companies operating in drug development and research activities. • In 2020, North America accounted for the largest share of the AI in Genomics market, followed by Europe. The large share of North America can be accredited to the increasing research funding and government initiatives for promoting precision medicine in the US. • For instance - Desktop Genetics, a London-based software company, at the convergence of AI and CRISPR. Founded in 2012, the company has accrued USD 5.8 million in total equity funding from 7 investors which include a mix of accelerators, venture capital firms and biotech company and DNA sequencing old-hand illumina. This 21 © 2021. All Rights Reserved | MarkNtel Advisors

  22. Global Artificial Intelligence in Genomics Market, By Offering (2/6) Figure XX: Global Artificial Intelligence in Genomics Market By Revenue (USD Million), By Revenue Share (Percentage), By Offering, 2020 & 2026F Revenue Share (Percentage) Revenues (USD Million), 2020-2026F CAGR- X% Software 2020 2026 Services 2020 2026F Software Services Source: MarkNtel Advisors Market Brief • This segment is bifurcated into software and services provided by multiple companies in the AI in Genomics market across the globe. This segment has been estimated to be USD XX billion as of 2019, and is expected to reach at USD XX billion in the forecasted period, from 2020 to 2026. The growing demand for genomics services, such as genome sequencing for precision medicine, predictive gene testing, preventive medicine, and direct-to-consumer services has escalated the demand for services for Artificial Intelligence in genomics market globally. • The direct-to-consumer genomics encompasses companies who offer genomic sequencing services to individual consumers. The companies in the field of drug development, healthcare and other related industries are using machine learning to achieve greater depth in the interpretation of genetic information, for illustration, how an individual’s genes may impact their weight, and other physical variables 22 © 2021. All Rights Reserved | MarkNtel Advisors

  23. Global Artificial Intelligence in Genomics Market, By Technology (1/6) Figure XX: Global Artificial Intelligence in Genomics Market By Revenue (USD Million), By Revenue Share (Percentage), By Technology, 2020 & 2026F Revenue Share (Percentage) Revenues (USD Million), 2020-2026F CAGR- X% Machine Learning 2020 2026 Other Technologies 2020 2026F Machine Learning Other Technologies Source: MarkNtel Advisors Market Brief • This chapter covers the various types of technologies that is used in genomics. This segment is categorized in machine learning, and other technologies. The most widely used is the machine learning. There are several categories under machine learning which can be used to predict, analyze, and map. Interpretable machine- learning methods are an active area of computer science research, but most interpretable AI approaches involve the production of a simplified and potentially inaccurate approximation of the more complex AI system. • Machine Learning had a significant market share for AI in Genomics market in 2020, which accounted for USD XX. It is expected to reach XX million by 2026 at a CAGR of X% during the forecast period. The high growth rate of this segment owes to the pharmaceutical companies, CROs, and biotechnology companies, which have widely adopted machine learning for drug genomics applications. 23 © 2021. All Rights Reserved | MarkNtel Advisors

  24. Global Artificial Intelligence in Genomics Market, By Functionality (1/4) Figure XX: Global Artificial Intelligence in Genomics Market By Revenue (USD Million), By Revenue Share (Percentage), By Functionality, 2020 & 2026F Revenue Share (Percentage) Revenues (USD Million), 2020-2026F Gene Editing CAGR- X% Genome Sequencing 2020 2026 Predictive Genetic Testing & Preventive Medicine 2020 Genome Sequencing 2026F Gene Editing Predictive Genetic Testing & Preventive Medicine Source: MarkNtel Advisors • This chapter is segmented into respective functionality of Artificial Intelligence in genomics market across the globe. It consists of gene editing, genome sequencing, and predictive genetic testing & preventive medicine. The functionality segmented has been valued at USD XX billion as of 2019, with XX%, XX%, and XX% being respective market share for this segment. • The market has been captured by genome sequencing, followed by predictive genetic testing & preventive medicine, as of 2020. It is expected to grow at a CAGR of XX% throughout 2021-2026. The rapid investment of government of developed nations, such the US, Canada, etc., and developing nations such as India, China, Japan, etc., in the field of AI-based genomics has been contributing to the growth. • The outbreak of COVID-19 in 2020 has established the need for predictive genetic testing and preventive medicine to take proactive measures in the fight against the infection. The exponentially growing number of coronavirus cases all across the globe has catalysed the investments from big tech companies, like Intel, Microsoft, etc. 24 © 2021. All Rights Reserved | MarkNtel Advisors

  25. Global Artificial Intelligence in Genomics Market, By Application (5/6) Figure XX: Global Artificial Intelligence in Genomics Market By Revenue (USD Million), By Revenue Share (Percentage), By Application, 2020 & 2026F Revenue Share (Percentage) Revenues (USD Million), 2020-2026F Diagnostics CAGR- X% Precision Medicine 2020 2026 Drug Discovery & Development Agriculture & Animal Research 2020 2026F Diagnostics Precision Medicine Drug Discovery & Development Agriculture & Animal Research Source: MarkNtel Advisors Market Overview • This segment is bifurcated into different applications of AI in Genomics Market. It consists of diagnostics, precision medicine, drug discovery & development, and agriculture & animal research. Diagnostics was the largest application segment in the AI in genomics market in 2019. • The increasing research on diseases and the decreasing costof sequencing has contributed to the demand for diagnostics segment globally. • Whereas, the field of Precision Medicine is an approach to patient care that encompasses genetics, behaviors and environment with a goal of implementing a patient or population-specific treatment intervention. For instance - to reduce the risk of complications, an individual who needs a blood transfusion would be matched to a donor who shares the same blood type instead of a randomly selected donor. 25 © 2021. All Rights Reserved | MarkNtel Advisors

  26. Global Artificial Intelligence in Genomics Market, By End User (6/6) Figure XX: Global Artificial Intelligence in Genomics Market By Revenue (USD Million), By Revenue Share (Percentage), By End User, 2020 & 2026F Revenue Share (Percentage) Revenues (USD Million), 2020-2026F Pharmaceutical Companies CAGR- X% Research Centers, Academic Institutes 2020 2026 Healthcare Providers Government Organizations 2020 2026F Pharmaceutical Companies Research Centers, Academic Institutes Healthcare Providers Government Organizations Source: MarkNtel Advisors Market Brief • The growing applicability of AI in various fields in healthcare has contributed to the growth of AI in genomics market. Various institutions and research centres around the world are developing ways to develop patient or population-specific pharmaceutical drugs. In agricultural area, AI is helping farmers improve soil quality and crop yield, and contribute to the development of advanced genetic screening tools. • Analysts anticipate that newborn genetic screening would become standard practice over the next decade. Data collected at birth would be seamlessly integrated into the individuals EHR, and non-invasive screening capabilities for particularly diseases such as Down Syndrome would be available to women during a pregnancy. • XX • XX 26 © 2021. All Rights Reserved | MarkNtel Advisors

  27. Global Artificial Intelligence in Genomics Market, By Company (3/4) Figure XX: Global Artificial Intelligence in Genomics Market, By Company, By Revenues, 2021 Deep Genomics Inc. (USD XX Million) Sophia Genetics (USD XX Million) XX  XX  XX XX XX   XX XX   XX XX  XX IBM (USD XX Million) Lantern Pharma (USD XX Million) XX USD XX Billion  XX  XX  XX  XX  XX  XX XX XX Microsoft Corporation (USD XX Million) FDNA Inc. (USD XX Million)  XX  XX  XX  XX  XX  XX Source: MarkNtel Advisors 27 © 2021. All Rights Reserved | MarkNtel Advisors

  28. North America Artificial Intelligence in Genomics Market Outlook, 2016-2026F

  29. North America Artificial Intelligence in Genomics Market, By Revenues (1/6) Figure XX: North America Artificial Intelligence in Genomics Market Revenues (USD Million), 2016-26F CAGR: X% CAGR: X% COVID-19 Impact 2016 2017 2018 2019 2020 2021F 2022F 2023F 2024F 2025F 2026F Source: MarkNtel Advisors Overview • The North American Artificial Intelligence in Genomics market was valued at USD X billion in 2020 and is projected to reach USD X billion by 2026, registering a compound annual growth rate (CAGR) of X% between 2021 and 2026 in terms of value. The growth in AI in the North American Genomics market can be ascribed to the remarkable adoption of machine learning in the medical sector, which is mainly responsible for increasing the market demand. • In North American region, the countries considered to analyze are the United States, Canada, and Mexico. At present, the U.S artificial intelligence in genomics market occupies the throne in this region. On the other hand, there has been evident initiatives taken up by the Canadian government to encourage companies do research and development in the field of genomics. • For instance - in 2017, the Canadian government allocated USD 100 million towards a Pan-Canadian Artificial Intelligence Strategy. This is expectedto establish gro- 29 © 2021. All Rights Reserved | MarkNtel Advisors

  30. Document Outline Table of Content Study Background, Market Segmentation, Scope of Work 02 Research Process & Methodology Research Approach, Research Methodology 17 Sample Illustration Global Artificial Intelligence in Genomics Market Analysis, 2021 28 Commercials 70 Company Profile About the company 72 Contact Details 74 30 30 © 2021. All Rights Reserved | MarkNtel Advisors

  31. Contact Us sales@marknteladvisors.com +1 (613) 707-5086, +91 8719999009 Follow Us on 31 © 2021. All Rights Reserved | MarkNtel Advisors

More Related